Navigation

  • Feed aggregator
    • Sources
logo

Search

Primary links

  • HOME
  • ABOUT US
    • Emerging Markets
  • services
    • Country & Site Selection
    • Regulatory
    • Site management
    • Clinical Monitoring
    • Medical Monitoring
    • Quality Assurance & Audits
    • Medical Translations
    • Trial Performance
  • Therapeutic Experience
  • countries
  • Patients & Sites
  • case studies
    • Cardiovascular Rescue
    • Atrial Fibrillation
    • Breast Cancer
  • contact

Sources

World Pharma News

  • AI designs a novel E. coli killer 3 weeks 2 days old
  • GLP-1 drug linked to heart benefits for high-risk patients 3 weeks 3 days old
  • FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber 3 weeks 4 days old
More

Biospace news

  • FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected 1 year 41 weeks old
  • Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff 1 year 41 weeks old
  • PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices 1 year 41 weeks old
More
Syndicate content

World Pharma News

  • AI designs a novel E. coli killer
  • GLP-1 drug linked to heart benefits for high-risk patients
  • FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber
  • Targeting MDA-9 restrains head and neck tumor growth and eliminates therapy resistance
  • Engineered human neurons rebuild damaged spinal cord circuits
more

© 2010 S&P Pharmaterra Management